Rate Video

ESH MM 2018 | Continuous vs. fixed duration therapy for multiple myeloma?

Jesús San Miguel • 5 Oct 2018

ESH MM 2018

Multiple Myeloma

Speaking from the European School of Haematology (ESH) International Conference on Multiple Myeloma 2018, held in Mandelieu, France, Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, discusses continuous and fixed duration therapy.

Early detection and intervention in myeloma: a critical point

Jesús San Miguel • 5 Oct 2018

Early treatment and novel therapeutic targets for multiple myeloma

Antonio Palumbo et al. • 11 Apr 2015

Treatment strategies for high-risk MM

Jesús San Miguel • 7 May 2020

Prognostic value of MRD and circulating plasma cells in myeloma

Jesús San Miguel • 16 Dec 2020

Related Videos

A.R.R.O.W. study: carfilzomib dosing in frail MM patients

Maria-Victoria Mateos

Managing CRS in myeloma

Managing transplant patients during the COVID-19 pandemic

Christian Chabannon

DNA methyltransferase inhibitors: daratumumab enhancement for MM